WO2003105492A2 - Method of data communication with implanted device and associated apparatus - Google Patents

Method of data communication with implanted device and associated apparatus Download PDF

Info

Publication number
WO2003105492A2
WO2003105492A2 PCT/US2003/016696 US0316696W WO03105492A2 WO 2003105492 A2 WO2003105492 A2 WO 2003105492A2 US 0316696 W US0316696 W US 0316696W WO 03105492 A2 WO03105492 A2 WO 03105492A2
Authority
WO
WIPO (PCT)
Prior art keywords
antenna
external device
implanted
current
implanted device
Prior art date
Application number
PCT/US2003/016696
Other languages
French (fr)
Other versions
WO2003105492A3 (en
Inventor
Mingui Sun
Robert J. Sclabassi
Marlin H. Mickle
Original Assignee
University Of Pittsburgh Of The Commonwealth System Of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Pittsburgh Of The Commonwealth System Of Higher Education filed Critical University Of Pittsburgh Of The Commonwealth System Of Higher Education
Priority to AU2003237263A priority Critical patent/AU2003237263A1/en
Publication of WO2003105492A2 publication Critical patent/WO2003105492A2/en
Publication of WO2003105492A3 publication Critical patent/WO2003105492A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0026Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the transmission medium
    • A61B5/0028Body tissue as transmission medium, i.e. transmission systems where the medium is the human body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/279Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/291Bioelectric electrodes therefor specially adapted for particular uses for electroencephalography [EEG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04Arrangements of multiple sensors of the same type
    • A61B2562/046Arrangements of multiple sensors of the same type in a matrix array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • A61B5/352Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/369Electroencephalography [EEG]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/903Radio telemetry
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Definitions

  • the present invention relates to a method and associated apparatus employed in
  • RF radio frequency
  • an implanted device has a first antenna having a pair of electrodes and
  • An external device has a second antenna having a pair of electrodes and an associated microprocessor.
  • the invention involves transmitting
  • the transmissions are preferably synchronously effected.
  • Corresponding apparatus is provided. '
  • first or volume conduction antenna facilitates directional
  • the system delivers of the information with high efficiency in the far field.
  • the efficiency of data communication is such as to enhance battery life.
  • implantable device in a human patient in regions such as the brain, torso or abdomen.
  • Figure 1 is a schematic illustration showing the general interaction between the
  • Figure 2 is a schematic illustration of a human patient.
  • Figure 3 is an illustration of a passive two-port system illustrating the reciprocity
  • Figure 4 is a perspective view of a form of preferred volume conduction antemia of
  • Figure 5 is an end elevational view of the volume conduction antenna of Figure 4.
  • Figure 6 is a left side elevational view of the antenna as shown in Figure 5.
  • Figure 7 illustrates a prior art form of dipole antenna and the corresponding current field.
  • FIG. 8 illustrates a preferred form of volume conduction antenna of the present
  • Figure 9 illustrates schematically a preferred form of synchronizing the
  • FIGS. 10(a) and 10(b) illustrate schematically the external and internal device
  • Figure 11 illustrates a form of implantable brain chip design with a first antenna of
  • the present invention having a pair of electrodes.
  • Figure 12 illustrates schematically functioning of the electrodes of Figure 11.
  • volume conduction means data communication by
  • the term "patient” means a member of the animal kingdom, including human beings.
  • current pulse(s) means electrical current waveforms
  • phase shift keying which have been modified to carry information such as by, for example, phase shift keying
  • antenna having a pair of electrodes for receiving and transmitting current pulses from and
  • Each antenna is associated with a microprocessor and related circuit components.
  • FIG. 1 there is shown a segment of living biological tissue 2 such as
  • first antenna 8 is in intimate contact with the living biological tissue 2 and is operatively associated with circuit components 10 which may be energized by battery 12 or another device that produces electrical current.
  • circuit components 10 which may be energized by battery 12 or another device that produces electrical current.
  • the implanted antenna 8, circuit components 10 and battery 12 may all be provided within a single housing (not shown) which may be
  • a biocompatible resinous material such as epoxy or
  • external second antenna 20 is in operative association with a microprocessor 22 which is energized by a suitable power source, which may be a suitable battery 24.
  • the circuit components 10 may include sensors to obtain information for delivery to the external device and, where appropriate, actuators and other elements desired for the particular use.
  • the present invention eliminates the need to rely on hard wired systems, transmitted energy as by light, sound, or RF and employs the
  • the distance "D” be less than about 15 cm. In general, this dimensional preference will be adequate to employ an implanted device within the human brain, torso, or abdomen, as well as other portions of the body, and will be able to communicate with an external device
  • portions which are representative of the antennas 8, 20 have port 34 providing a current
  • port 36 has a current source i which is identical to that for port 34, but at terminals 2-2'
  • output of the system can be interchanged without altering the response of the system to a
  • the volume conduction based data communication system produces the
  • the preferred first antenna 40 has a suitable
  • Shells 44, 46 have inner generally convex surfaces 50, 52, respectively, which
  • the shells are preferably made of a corrosion resistant material
  • metallic or nonmetallic electrically conductive material such as a suitable metal such as
  • convex surfaces 50, 52 a coating of an electrically insulating material.
  • conductors 60, 62 are positioned in relative spaced relationship and illustrate the current
  • the shells 44, 46 are asymmetrical and have the upper portion which may be
  • the preferred antenna as shown in Figure 8, will preferably be employed solely in
  • the first column shows the received signal strength in mV (peak value) for each three levels.
  • the first column under each antenna heading indicates the required
  • ECG electrocardiographic
  • external device facilitate: (1) providing efficient communication; (2) eliminating the need
  • the initial Idle Phase has an R-wave
  • a positive pulse designated "A” which is transmitted by the external device to the implanted device during the idle phase.
  • This current pulse is a request for the implanted device to transmit data.
  • a signal labeled "B” is sent by the
  • a negative pulse such as pulse "C" is sent by the external device during the
  • the implanted device then switches to the receiving mode and
  • the present invention More specifically, in monitoring the heart involvement, the
  • second antenna has a pair of body surface electrodes 100 which receive the ECG signals
  • transmission/reception antenna electrodes 120 which, depending upon whether it is signal
  • FIG. 8 shown as 8 in Figure 1 represented by 190 in Figure 10(b) has a system control switch 192,
  • a desired delay 200 activates the switch 192. If the signal is "A,” biological data 210,
  • the system may be operated ignoring the peaks of the ECG for a
  • a further alternative would be to build a buffer and transmit
  • the reduced size of the unit permits an
  • the implanted device or electronic capsule 270 includes an
  • the implanted device is positioned on a flexible sheet 272, which may be plastic
  • each electrode 276, 281 as viewed from an end such as perpendicular to
  • electrode 276, for example, will appear to be generally rectangular.
  • the flexible, transparent, thin plastic sheet 272 may be provided in a variety of sizes and
  • connection lead and connector are removed so as to convert this
  • FIG. 11 structure of Figure 11 may be used for diagnostic and monitoring functions as by recording
  • subdural EEG may also be used therapeutically in stimulating the brain.
  • device 270 may contain amplifiers, modulators and internal data communication subsystem,
  • the first antenna electrodes 276, 281, in the form shown, are integrated with the implanted device 270 at the ends thereof. These electrodes are
  • the volume conduction first antenna 270 which has
  • electrodes 276, 281 is a directional antenna with the emitted current pulses, as exemplified
  • the plastic sheet 272 is flexible
  • the flexible sheet 272 functions as a reflector which
  • volume conduction may be employed.
  • the ionic fluid of biological tissue such as
  • cerebrospinal fluid for example, is highly electrically conductive. Certain preferred

Abstract

The present invention provides a method of communicating data employing current pulses transmitted by an implanted device through living biological tissue to an external device. The method also contemplates transmission of current pulses from the external device through living biological tissue to an implanted device. Uniquely configured antenna electrodes are preferably employed in the implanted device. Increase in signal-to-noise ratio is achieved through synchronization. The method may be employed in diagnostic, therapeutic and general monitoring activities in connection with human beings. Corresponding apparatus is disclosed.

Description

METHOD OF DATA COMMUNICATION WITH IMPLANTED DEVICE AND
ASSOCIATED APPARATUS
STATEMENT OF GOVERNMENT INTEREST
The United States Government has rights under this invention pursuant to Grant 1-
R01-NS43791 from the National Institutes of Health.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a method and associated apparatus employed in
wireless two-way communication of data by means of current pulses traveling through
living biological tissues and, more specifically, it contemplates the use of an implantable
device which may be implanted, for example, in a patient's brain, torso or abdomen in
cooperation with an external computerized device for diagnostic, monitoring or therapeutic
purposes.
2. Description o the Prior Art
The value of using invasive procedures and devices in diagnosing, monitoring or
treating patients has long been known in the medical environment. It has been known, for
example, to employ a pacemaker for regulating heart functions. Also, deep brain electrical
stimulation for the treatment of Parkinson's Disease has been known.
It has also been known to suggest the use of implantable devices which are in
communication with an external computerized device, such as by radio frequency (RF)
signals or light or wired connection, for example. It has also been known for various purposes to suggest two-way communication with wireless base and remote stations wherein data may be communicated. See, for
example, U.S. Patent 6,289,237.
Among the problems with the prior art utilizing wired systems are the risk of infection and reduced mobility of the patient.
Among the problems with prior art RF systems have been the requirement for
substantial size, difficulty in recharging batteries and signal-to-noise ratio. Also the energy
required to convert between the signal and the RF waves can be substantial.
There remains, therefore, a substantial need for an implantable device which will
efficiently and accurately receive signals from an external device and deliver signals to the
external device for medical diagnosis, monitoring and therapeutic purposes.
SUMMARY OF THE INVENTION
The present invention has met the above-described need. In the method of the present invention, an implanted device has a first antenna having a pair of electrodes and
associated first circuit components. An external device has a second antenna having a pair of electrodes and an associated microprocessor. The invention involves transmitting
current pulses containing data through living biological tissue, thereby taking advantage of
the electrical conductivity of the ionic fluid of such biological tissue. The data transmission
may be effected in both directions, i.e., from the external device to the internal device and
from the internal device to the external device. The transmissions are preferably synchronously effected. Corresponding apparatus is provided. '
A unique construction of first or volume conduction antenna facilitates directional
delivery of the information with high efficiency in the far field. The efficiency of data communication is such as to enhance battery life. The system
also facilitates miniaturization, including the use of microchip technology.
It is an object of the present invention to provide a method and associated apparatus
for providing efficient communication between an implanted device and an external device
for purposes of data transmission employing volume conduction.
It is another object of the present invention to provide such a system which can be
miniaturized and make efficient use of energy employed to power the system.
It is a further object of such an invention which facilitates implantation of the
implantable device in a human patient in regions such as the brain, torso or abdomen.
It is yet another object of the present invention to provide such a system which does
not require the use of wires for purposes of power delivery or data transmission or the use
of light, magnetic field, ultrasound or RF energy.
It is a further object of the present invention to provide such a system which takes
advantage of the electrical current carrying capabilities of the body's ionic fluid in order to
employ the same as an information carrier.
It is yet another object of the present invention to provide such a system which
facilitates efficient synchronous communication of current pulses through living biological
tissues.
These and other objects of the invention will be more fully understood from the
following detailed description of the invention on reference to the illustrations appended
hereto.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a schematic illustration showing the general interaction between the
implantable device and the external device. Figure 2 is a schematic illustration of a human patient.
Figure 3 is an illustration of a passive two-port system illustrating the reciprocity
theorem.
Figure 4 is a perspective view of a form of preferred volume conduction antemia of
the present invention.
Figure 5 is an end elevational view of the volume conduction antenna of Figure 4.
Figure 6 is a left side elevational view of the antenna as shown in Figure 5.
Figure 7 illustrates a prior art form of dipole antenna and the corresponding current field.
Figure 8 illustrates a preferred form of volume conduction antenna of the present
invention and its associated current flow.
Figure 9 illustrates schematically a preferred form of synchronizing the
communication of the present invention with the heart action as monitored through an electrocardiogram. Figures 10(a) and 10(b) illustrate schematically the external and internal device
functioning in the context of Figure 9.
Figure 11 illustrates a form of implantable brain chip design with a first antenna of
the present invention having a pair of electrodes.
Figure 12 illustrates schematically functioning of the electrodes of Figure 11.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
As used herein, the term "volume conduction" means data communication by
wireless passage of data by current pulses passing through living biological tissues between an implanted device and an external device. As used herein, the term "patient" means a member of the animal kingdom, including human beings.
As employed herein, the term "current pulse(s)" means electrical current waveforms
which have been modified to carry information such as by, for example, phase shift keying,
amplitude modulation or frequency modulation.
The present invention makes advantageous use of an implanted device having a first
antenna having a pair of electrodes for receiving and transmitting current pulses from and
to an external device having a second antenna having a pair of electrodes and employing the external second antenna to deliver and receive current pulses to and from the implanted first antenna. Each antenna is associated with a microprocessor and related circuit components.
The use of suitably processed current to deliver pulsed current information
eliminates a number of the aforementioned problems. In the present context, passage of the current pulses which may be made to contain the desired information as by modulation through living biological tissues takes advantage of the fact that ionic fluid in biological tissues conducts electric current efficiently. This, therefore, prolongs the life of and reduces the size of any battery that would be employed in the implantable device. It also
eliminates the need for conversion of light, sound, or RF signals to digital signals for
purposes of data communication.
This further permits miniaturization which facilitates the use of microelectronic chips, as in implantable brain devices of the present invention.
Referring to Figure 1 , there is shown a segment of living biological tissue 2 such as
provided in a patient and skin 4 disposed exteriorly thereof. An internal volume conduction
first antenna 8 is in intimate contact with the living biological tissue 2 and is operatively associated with circuit components 10 which may be energized by battery 12 or another device that produces electrical current. The implanted antenna 8, circuit components 10 and battery 12 may all be provided within a single housing (not shown) which may be
suitable protectively encapsulated within a biocompatible resinous material such as epoxy or
other synthetic material having the desired durability, sealing properties and inertness. The
external second antenna 20 is in operative association with a microprocessor 22 which is energized by a suitable power source, which may be a suitable battery 24.
In general, the system, in a manner to be described hereinafter in detail,
contemplates two-way communication employing current pulses traveling between the external second antenna 20 and the implanted first antenna 8 in either direction in
synchronized fashion. The circuit components 10 may include sensors to obtain information for delivery to the external device and, where appropriate, actuators and other elements desired for the particular use. The present invention eliminates the need to rely on hard wired systems, transmitted energy as by light, sound, or RF and employs the
biological tissue electric conductivity characteristics to carry current pulses which contain
the desired information.
As shown in Figure 2, a center line of a standing human being has been identified as
30 with the dimension D between the outermost portion of the internal first antenna 8 and the innermost portion of the external second antenna 20 which will generally be in contact
with skin 4 being designated by the letter "D. " In humans, it is presently preferred that the distance "D" be less than about 15 cm. In general, this dimensional preference will be adequate to employ an implanted device within the human brain, torso, or abdomen, as well as other portions of the body, and will be able to communicate with an external device
with adequate signal strength for effective communication. Referring to Figure 3, there is illustrated a linear two-port network NR with two
different connections. It will be seen that, in accordance with the reciprocity theorem these
portions which are representative of the antennas 8, 20 have port 34 providing a current
source i at terminals 1-1' which produces an open circuit voltage at 2-2' of v. Similarly,
port 36 has a current source i which is identical to that for port 34, but at terminals 2-2'
and produces an open circuit voltage at terminals 1-1' of v' . Under the reciprocity
theorem, v = v' regardless of the topology within NR. This means that the input and
output of the system can be interchanged without altering the response of the system to a
given waveform. In the present environment this means that reversing the
transmission/reception modes of the internal first volume conduction antenna 8 and the
external second antenna 20 the received, voltage will not vary. As a result, under the same
excitation current, the volume conduction based data communication system produces the
same output regardless of whether the information is flowing from the external device to
the internal device or in the reverse direction.
Referring to Figures 4 through 8, a preferred form of first volume conduction
antenna of the present invention will be considered.
As shown in Figures 4 through 6, the preferred first antenna 40 has a suitable
electrical connection through wires 42, 43 to other circuit components 10 (not shown in this
view) and has a pair of concave shells 44, 46 facing outwardly in generally opposed
directions. Shells 44, 46 have inner generally convex surfaces 50, 52, respectively, which
in the form shown, are joined at 56. The shells are preferably made of a corrosion resistant
metallic or nonmetallic electrically conductive material, such as a suitable metal such as
stainless steel or brass, carbon or a conductive polymer, for example, and have on their
convex surfaces 50, 52 a coating of an electrically insulating material. Referring to the prior art dipole construction shown in Figure 7, a pair of electrical
conductors 60, 62 are positioned in relative spaced relationship and illustrate the current
field exhibited by such construction. This shows that the majority of the current flux goes
directly from the positive pole 60 to the negative pole 62, thereby providing a strong
shorting current which not only wastes power, but also promotes tissue damages at the
source site and other adverse effects which might interfere with a vital organ's activity,
such as cardio-pulmonary, nervous or muscular functions. It is also noted that the use of
far- field components of the antenna field, which contributes the transfer of information, is
relatively weak.
While the individual shells 44, 46 may be symmetrical, in the preferred form of the
invention, the shells 44, 46 are asymmetrical and have the upper portion which may be
considered to be above the horizontal bisector between the lowermost portion and
uppermost of the shell elongated with respect to the lower. This serves to provide the
desired directional transmission.
Also shown in Figure 8 is the fact that the generally x-shaped configuration of the
antenna electrodes, combined with the insulators blocking short circuiting, force the current
to flow around longer paths thereby increasing the far-field as the amount of current
flowing through the conductor volume is the same in both Figures 7 and 8. The flux lines
of the upper portion, as represented by reference number 60 are longer than the flux lines
of the lower portions 62.
The preferred antenna, as shown in Figure 8, will preferably be employed solely in
the implanted first volume conductive antenna 8 and not in the external second antenna 20.
A comparison between the x- shaped electrode pair, as shown in Figure 8, was made with
the known dipole antenna as shown in Figure 7, wherein both antennas had a width of 7 mm. In each instance, the transmitted sinesoidal current signal was 1 KHz and the received
voltage signal by the external electrodes 15 cms from the internal electrodes was measured.
The results are shown in Table 1.
Table 1
Figure imgf000010_0001
The first column shows the received signal strength in mV (peak value) for each three levels. The first column under each antenna heading indicates the required
transmission current inμA (peak value), followed by the transmission voltage in mV (peak
value) and power consumption in μψ. It will be seen that for the same output, the new
antenna required only about 30-35 % of the transmission current, 3-6% of the transmission voltage and 1-2% of the power, as compared with the known prior design as shown in Figure 7. These results confirm the fact that the present invention facilitates
miniaturization, lower power consumption and longer battery life or the use of a smaller
battery or other power source while preserving the desired communication efficiency. Among the enhanced difficulties between the use of an internal device within a
living patient and an external device effecting bi-directional communication therebetween are the fact that in a live biological body, there is a noisy environment due to the ongoing activity of heartbeat, arterial pulses and muscle activity, for example. Also, the internal
and external devices must coordinate their data communication paths so as to provide for
synchronized bidimensional communication while taking advantage of volume conduction characteristics of current pulse flow through live biological tissue. All of this must be accomplished employing an internal device which preferably is of small size, light weight
and watertight.
A preferred way of accomplishing the foregoing in the present invention is to
employ the electrocardiographic (ECG) signal as a clock for synchronization.
Referring to Figure 9, a time frame reference moving horizontally from left to right
is provided graphically. As will be appreciated in the description which follows, use of the
cardiac ECG as a reference, combined with exchange between the internal device and the
external device facilitate: (1) providing efficient communication; (2) eliminating the need
for an external clock mechanism which synchronizes the activities of the implanted device and external device; and (3) maximizing signal-to-noise ratio and, in particular, minimizing
the noisy effect created by the heart pumping and deformation of major arteries.
Referring to Figure 9, there is shown in the uppermost portion, the sharp peaks designated R-waves and shown as "R," with the delta symbol and two-spaced lines
indicating that communication between the external device and internal device will not
occur during that period. As a result of not communicating during the R-wave, this source
of noise which has the potential to interfere with efficient communication between the external device and the internal device is avoided. Underlying the plot of the ECG are the
plots of the external device and the implanted device. The initial Idle Phase has an R-wave
followed by a positive pulse designated "A" which is transmitted by the external device to the implanted device during the idle phase. This current pulse is a request for the implanted device to transmit data. In response, a signal labeled "B" is sent by the
implanted first antenna 8 to the external second antenna 20 (Fig. 1) during the Active Phase. This transmission/reception halts automatically after a certain predetermined period of time. If the data transmission has not been completed, a positive going pulse A is sent
again upon the arrival of the next R-wave by the external device and the process repeats
(not shown). If the external device would like to send commands or instructions to the
internal device, a negative pulse, such as pulse "C" is sent by the external device during the
Idle Phase after an R-wave. The implanted device then switches to the receiving mode and
a signal wave labeled "D" is put on the channel by the external device during the quiescent
period of the ECG in an Active Phase. It will be appreciated that the illustration in Figure
9 is for conceptual purposes and in actual functioning the waveforms "A," "B," "C" and
"D" would be modulated and well defined waveforms suitable for transmission through the
communication channel to take advantage of the volume conduction.
The flow diagrams of Figures 10(a) and 10(b) illustrate schematically flow diagrams
of ways in which the concepts of Figure 9 may be implemented in achieving the objectives
of the present invention. More specifically, in monitoring the heart involvement, the
second antenna has a pair of body surface electrodes 100 which receive the ECG signals
which are amplified at 102 and converted into a digital equivalent at analog-to-digital
converter (A/D) 104, followed by peak detection 110 delayed by the increment delta 112
and generation of signals "A" or "C" 114. The control signal is then introduced into the
transmission/reception antenna electrodes 120 which, depending upon whether it is signal
"B," meaning that it is the implanted device emitting the signal, or signal "D," meaning
that it is the external device emitting the signal, an appropriate position of control switch
132 will be employed. If it is signal "B, " there is amplification 134, analog-to-digital
conversion 136, signal processing 138 in the microprocessor 22 (Fig. 1), demodulation 140
and the emitted biological data 142 which has been communicated. With the signal "D"
emitted by the external device with a command signal 150 passing through the digital logic shaping station 152, followed by modulation 154 and digital-to-analog conversion 156,
amplification 158 and current drive which provides an appropriate amount of power to be
emitted by the skin-surface external electrodes 160.
Referring now to Figure 10(b) and the implanted device, the implanted antenna
shown as 8 in Figure 1 represented by 190 in Figure 10(b) has a system control switch 192,
which, depending upon which of the four signals in the example shown in Figure 9 is being
employed will be in an appropriate position. If the signal is "A" or "C," it is amplified
194, is detected for a "A" or "C" 196, which is subjected to digital logic 198, which, after
a desired delay 200, activates the switch 192. If the signal is "A," biological data 210,
after amplification 212, filtering 220 and modulation 222, all in analog form, are sent to the
electrodes by current driver 224 for transmission through drive signal "B." If the status is
"C," signal "D" is received from the electrodes 190, is amplified 230, demodulated 232
and is converted to appropriate digital form and processed by digital logic 234, after which
the suitable commands/instructions 236 are provided.
If desired, the system may be operated ignoring the peaks of the ECG for a
specified number of R-waves. A further alternative would be to build a buffer and transmit
each packet of data at a faster or slower rate than real-time, as desired for specific
applications..
It will be appreciated that a central benefit of the present invention is the ability to
transmit current pulses efficiently and synchronously through live biological tissues
between implanted and external devices. The reduced size of the unit permits an
encapsulated implantable device employing the benefits of microelectronic chips, for
example, in the brain, torso, or abdomen or other portions of the body. Referring to Figures 11 and 12, examples of a preferred use in respect of the brain
will be considered.
In this embodiment, the implanted device or electronic capsule 270 includes an
electrically insulative material 274 interposed between the electrodes 276, 281 of the first
antenna. The implanted device is positioned on a flexible sheet 272, which may be plastic
with an underlying plurality of subdural electrode contacts shown generally at 277, 280,
282, for example.
In this form of the implanted first antenna, a pair of outwardly concave electrodes
276, 281 are separated by the large electrically insulating element 274 which may contain
or have secured thereto first circuit components. Unlike the embodiment shown in Figures
4-6 and 8, each electrode 276, 281, as viewed from an end such as perpendicular to
electrode 276, for example, will appear to be generally rectangular.
The first antenna assembly may advantageously form part of an electronic chip
which is encapsulated and implanted in the brain region between the skull and the brain.
The flexible, transparent, thin plastic sheet 272 may be provided in a variety of sizes and
shapes. Similar sheets are commercially available for subdural EEG recording during
diagnosis of epilepsy. The connection lead and connector are removed so as to convert this
system from wire transmission to wireless transmission. The first antenna electrode 276,
281, in the form illustrated, are altered in shape and size, but retain the beneficial
properties of the type disclosed herein in Figures 4-6 and 8. It will be appreciated that the
structure of Figure 11 may be used for diagnostic and monitoring functions as by recording
subdural EEG and may also be used therapeutically in stimulating the brain. The implanted
device 270 may contain amplifiers, modulators and internal data communication subsystem,
and a power source. The first antenna electrodes 276, 281, in the form shown, are integrated with the implanted device 270 at the ends thereof. These electrodes are
externally concave and may be covered with a gold foil to establish the two x-electrode
surfaces.
The implantable device 270 with the integrated first antenna electrodes 276, 281
preferably has a width of less than about 12 mm, a length of less than about 12 mm and a
thickness of less than about 4 mm.
As shown in Figure 12, the volume conduction first antenna 270, which has
electrodes 276, 281, is a directional antenna with the emitted current pulses, as exemplified
by lines 290, 292, being delivered generally in the direction of external second antenna
electrodes 300, 320, which are in contact with the scalp. The plastic sheet 272 is flexible,
thereby permitting it to be deformed freely to conform to the exterior shape of the cortex.
In the case where the recording/stimulation task will be performed within a sulcus, a
smaller flexible sheet with thinner contacts would be utilized to facilitate insertion into the
sulcus. A further alternative would be to use nanotube material to construct
stimulation/recording electrodes.
Among the advantages of the embodiment of Figures 11 and 12 are the use of a
relatively large surface area at each x-antenna electrode piece, thereby reducing the current
density in brain tissue surrounding the antenna electrodes and improving electrical contact
with the electrically conductive fluid within the brain. It also increases the efficiency of the
transmitter because of the larger separation, which may be on the order of 12 mm between
the two electrode surfaces. It further eliminates the need for a stand alone antenna
electrodes, thereby reducing the size of the implantable device and facilitating placement
during neurosurgery. Further, the flexible sheet 272 functions as a reflector which
strengthens the current field in direction of reception and weakens the current flowing from and into the brain. This latter feature is important, as it reduces the undesired brain
stimulation as the brain current shown in the dashed curve designated 330 is smaller than
the current in the direction of transmission.
While, for purposes of illustration herein, focus has been placed upon use of the
present invention in respect of brain, torso, and abdominal introduction of the implanted
device, it will be appreciated that a wide number of applications wherein an implantable
device can communicate information and receive information through the advantageous use
of volume conduction may be employed.
It will be appreciated that the present invention may be used for diagnostic and
monitoring functions, as well as for therapeutic activity. For example, obtaining
information regarding brain functioning, such as EEG and therapeutic use through
energizing the electrodes in deep-brain stimulation such as described in respect of Figures
11 and 12, may be beneficially provided. Further, examples of utility are in epileptic
seizure monitoring and intervention and bypassing brain signals to control limb movement
for people with spinal cord injuries.
It will be appreciated, therefore, that the present invention provides a unique method
and associated apparatus for efficiently having synchronized, two-way communication
between an internal device and an external device through current pulse conduction through
living biological tissues has been provided. The ionic fluid of biological tissue, such as
cerebrospinal fluid, for example, is highly electrically conductive. Certain preferred
features such as a highly efficient antenna which facilitates enhanced signal-to-noise ratio
and directional delivery and receipt of signals are provided. In addition, certain noise
reducing embodiments such as avoidance of the heart noise disturbances have also been
provided. Whereas particular embodiments of the invention have been described herein for
purposes of illustration, it will be evident to those skilled in the art that numerous variations
may be made without departing from the invention as set forth in the appended claims.

Claims

We Claim:
1. A method of data communication between an implanted device and an
external device comprising
providing an implanted device having a first antenna and first circuit components
operatively associated therewith,
providing an external device having a second antenna and an associated
microprocessor,
positioning said first antenna and said second antenna with living biological tissue
therebetween, and
effecting communication between said implanted device and said external device to
establish current pulses in at least one direction between said first antenna electrode and
said second antenna electrode.
2. The method of claim 1, including
implanting said implanted device in a living patient.
3. The method of claim 2, including
implanting said implanted device in a human being.
4. The method of claim 3, including
effecting said communication both from said first antenna to second antenna and
from said second antenna to said first antenna.
5. The method of claim 4, including
effecting said communication in a synchronous manner.
6. The method of claim 5, including
employing heart pulses of said human being as a clock in synchronizing said
communications.
7. The method of claim 4, including
providing a microprocessor as one of said first circuit components.
8. The method of claim 7, including
providing at least one sensor as one of said first circuit components.
9. The method of claim 8, including
implanting said implanted device in the brain of said human being.
10. The method of claim 4, including
implanting said implantable device in the abdomen of said human being.
11. The method of claim 9 , including
employing said method to monitor brain functioning.
12. The method of claim 10, including
employing said method to communicate subdural electroencepholographic signals to
said external device.
13. The method of claim 1, including
establishing the distance between said first antenna and said second antenna at less
than about 15 cm.
14. The method of claim 1, including
employing in said first antenna a pair of electrically conductive concave shells
having their concave surfaces facing in generally opposed directions from each other.
15. The method of claim 14, including
said electrically conductive concave shells having generally concave surfaces facing
each other, and
electrically insulating the convex surfaces of said electrically conductive shells of
said first antenna from each other.
16. The method of claim 4, including
placing the electrodes of said second antenna in contact with the skin of said human
being.
17. The method of claim 1, including
employing said method for diagnostic purposes.
18. The method of claim 1, including
employing said method for therapeutic purposes.
19. The method of claim 1, including
providing a power source as a said first circuit component in said implanted device.
20. The method of claim 1 , including
providing said first circuit components on an electronic chip.
21. The method of claim 20, including
providing said implanted first antenna on said electronic chip.
22. The method of claim 1, including
protectively encapsulating said implanted device with a resinous material.
23. The method of claim 1, including
directing the current pulses from said implanted first antenna through said biological
material to said external second antenna.
24. The method of claim 20, including
providing an electrically nonconductive flexible sheet to reflect brain current flux
and resist said fluid contacting said first antenna.
25. The method of claim 1 , including
employing said first antenna and said second antenna for both transmission and
reception of said current pulses.
26. The method of claim 1, including
said implantable device having a width of less than about 12 mm, a length of less
than about 12 mm and a thickness of less than about 4 mm.
27. The method of claim 8, including
employing said external device to transmit a current pulse to cause said internal
device to transmit data, said internal device responsively transmitting said data to said external device, and
said transmissions being effected at times other than the period of R-waves of an
electrocardiogram.
28. The method of claim 27 including said external device emitting a current pulse or pulses of the different sign or configuration from the pulses it emits when it requests data from said implanted device when it wishes to transmit data to said implanted device, and
said external device following said pulses with the desired transmitted data to said
implanted device with said pulses being transmitted at a time other than the time period when R-waves of the electrocardiogram are present.
29. The method of claim 21 , including
positioning said first antenna up to about 15 cm from said second antenna electrode.
30. The method of claim 14, including said shells being asymmetrical.
31. Apparatus for volume conduction between an implantable device and an
external device, comprising an implantable device having a first antenna and first circuit components for
transmitting current pulses through living biological tissue and receiving current pulses
therethrough,
a second antenna for transmitting current pulses through living biological tissue and
receiving current therethrough,
said first circuit components including a first microprocessor,
said external device having a second microprocessor,
said first antenna being a directional antenna, and
said apparatus being structured for directional data communication.
32. The apparatus of claim 31, including
employing in said first antenna electrodes having a pair of electrically conductive
concave shells facing in generally opposed directions from each other, and
said second antenna for contacting the skin generally adjacent said biological tissue.
33. The apparatus of claim 32, including
said antenna electrodes being asymmetrical.
34. The apparatus of claim 31, including
said first circuit components including at least one sensor.
35. The apparatus of claim 34, including
said implantable device structured to deliver EEG data to said external device.
36. The apparatus of claim 35, including
said antenna electrode shells having convex surfaces generally facing each other,
and
electrical insulation disposed on said convex surfaces.
37. The apparatus of claim 35, including said first circuit components including at least one power source.
38. The apparatus of claim 31, including
said implantable device being configured and dimensioned to be implantable in a
human abdomen.
39. The apparatus of claim 38, including
said implantable device having a width less than about 12 mm, a length less than
about 12, and a thickness less than about 4 mm.
40. The apparatus of claim 37, including
an electrically nonconductive flexible sheet for reflecting brain current flux away
from said first antenna disposed on the opposite side of said first antenna electrode from said second antenna.
41. An antenna for transmitting current through biological tissue comprising a pair of electrically conductive concave shells facing in opposed directions from
each other.
42. The apparatus of claim 41, including
said concave shells having convex surfaces generally facing each other, and
electrically insulative material disposed on said convex surfaces.
43. The apparatus of claim 42, including said antenna electrodes being asymmetrical.
44. The apparatus of claim 41, including said antennas having a maximum thickness of less than about 4 mm.
45. The apparatus of claim 43, including
said antenna having an upper portion that is longer than the lower portion measured along the electrode.
46. The apparatus of claim 41, including
said concave shells having a generally circular configuration as viewed in end
elevations.
47. The apparatus of claim 46, including said antenna electrodes being generally symmetrical.
48. The apparatus of claim 41, including
said concave shells having a generally rectangular configuration as viewed in end
elevation.
PCT/US2003/016696 2002-06-06 2003-05-28 Method of data communication with implanted device and associated apparatus WO2003105492A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003237263A AU2003237263A1 (en) 2002-06-06 2003-05-28 Method of data communication with implanted device and associated apparatus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/164,517 US6847844B2 (en) 2002-06-06 2002-06-06 Method of data communication with implanted device and associated apparatus
US10/164,517 2002-06-06

Publications (2)

Publication Number Publication Date
WO2003105492A2 true WO2003105492A2 (en) 2003-12-18
WO2003105492A3 WO2003105492A3 (en) 2004-03-25

Family

ID=29710231

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/016696 WO2003105492A2 (en) 2002-06-06 2003-05-28 Method of data communication with implanted device and associated apparatus

Country Status (3)

Country Link
US (2) US6847844B2 (en)
AU (1) AU2003237263A1 (en)
WO (1) WO2003105492A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9365649B2 (en) 2003-04-14 2016-06-14 Xintela Ab Monoclonal antibody capable of binding integrin alpha 10 beta 1

Families Citing this family (185)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534207B2 (en) * 2003-02-07 2009-05-19 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Implantable device with sensors for differential monitoring of internal condition
EP1706178B1 (en) * 2004-01-22 2013-04-24 Rehabtronics Inc. System for routing electrical current to bodily tissues via implanted passive conductors
US20100016929A1 (en) * 2004-01-22 2010-01-21 Arthur Prochazka Method and system for controlled nerve ablation
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8391990B2 (en) 2005-05-18 2013-03-05 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
WO2006135520A1 (en) * 2005-06-09 2006-12-21 The Regents Of The University Of California Volumetric induction phase shift detection system for determining tissue water content properties
JP5249024B2 (en) 2005-06-28 2013-07-31 バイオネス インコーポレイテッド Improvements to implants, systems and methods using embedded passive conductors that conduct current
US8027727B2 (en) 2005-08-29 2011-09-27 Cardiac Pacemakers, Inc. Pacemaker RF telemetry repeater and method
JP5714210B2 (en) 2005-09-01 2015-05-07 プロテウス デジタル ヘルス, インコーポレイテッド Implantable wireless communication system
US7682313B2 (en) 2005-11-23 2010-03-23 Vital Sensors Holding Company, Inc. Implantable pressure monitor
US7686768B2 (en) 2005-11-23 2010-03-30 Vital Sensors Holding Company, Inc. Implantable pressure monitor
WO2007079490A2 (en) * 2006-01-05 2007-07-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education A wireless autonomous device system
US7528698B2 (en) * 2006-01-05 2009-05-05 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Multiple antenna energy harvesting
US20070191908A1 (en) * 2006-02-16 2007-08-16 Jacob Doreen K Method and apparatus for stimulating a denervated muscle
US7672732B2 (en) * 2006-03-31 2010-03-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Portable apparatus that delivers power and information to implantable devices
WO2007124128A2 (en) * 2006-04-20 2007-11-01 Liquidia Technologies, Inc. Biological vessel flow control devices and methods
JP2009544338A (en) 2006-05-02 2009-12-17 プロテウス バイオメディカル インコーポレイテッド Treatment regimen customized to the patient
US8391375B2 (en) * 2006-05-05 2013-03-05 University of Pittsburgh—of the Commonwealth System of Higher Education Wireless autonomous device data transmission
EP2063766B1 (en) * 2006-09-06 2017-01-18 Innurvation, Inc. Ingestible low power sensor device and system for communicating with same
WO2008030481A2 (en) * 2006-09-06 2008-03-13 Innurvation, Inc. Imaging and locating systems and methods for a swallowable sensor device
US8512241B2 (en) 2006-09-06 2013-08-20 Innurvation, Inc. Methods and systems for acoustic data transmission
US8483820B2 (en) * 2006-10-05 2013-07-09 Bioness Inc. System and method for percutaneous delivery of electrical stimulation to a target body tissue
EP2087589B1 (en) 2006-10-17 2011-11-23 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
EP2083680B1 (en) 2006-10-25 2016-08-10 Proteus Digital Health, Inc. Controlled activation ingestible identifier
EP2069004A4 (en) 2006-11-20 2014-07-09 Proteus Digital Health Inc Active signal processing personal health signal receivers
WO2008066424A1 (en) * 2006-11-30 2008-06-05 St. Jude Medical Ab Device and method for initiating communication with a selected implantable medical device by means of a directional antenna
ES2930588T3 (en) 2007-02-01 2022-12-19 Otsuka Pharma Co Ltd Ingestible Event Marker Systems
KR101528748B1 (en) 2007-02-14 2015-06-15 프로테우스 디지털 헬스, 인코포레이티드 In-body power source having high surface area electrode
EP2124725A1 (en) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
WO2008154504A2 (en) 2007-06-08 2008-12-18 William Marsh Rice University System and method for intra-body communication
US9757554B2 (en) 2007-08-23 2017-09-12 Bioness Inc. System for transmitting electrical current to a bodily tissue
US8738137B2 (en) 2007-08-23 2014-05-27 Bioness Inc. System for transmitting electrical current to a bodily tissue
JP5425077B2 (en) * 2007-08-23 2014-02-26 バイオネス インコーポレイテッド System for transmitting current to body tissue
FI2192946T3 (en) 2007-09-25 2022-11-30 In-body device with virtual dipole signal amplification
US9197470B2 (en) * 2007-10-05 2015-11-24 Innurvation, Inc. Data transmission via multi-path channels using orthogonal multi-frequency signals with differential phase shift keying modulation
KR101586193B1 (en) 2007-11-27 2016-01-18 프로테우스 디지털 헬스, 인코포레이티드 Transbody communication systems employing communication channels
AU2009221781B2 (en) 2008-03-05 2014-12-11 Otsuka Pharmaceutical Co., Ltd. Multi-mode communication ingestible event markers and systems, and methods of using the same
JP4475343B2 (en) * 2008-04-04 2010-06-09 村田機械株式会社 E-mail gateway device
US20090326602A1 (en) 2008-06-27 2009-12-31 Arkady Glukhovsky Treatment of indications using electrical stimulation
MY154234A (en) 2008-07-08 2015-05-15 Proteus Digital Health Inc Ingestible event marker data framework
US8617058B2 (en) * 2008-07-09 2013-12-31 Innurvation, Inc. Displaying image data from a scanner capsule
CN102112045B (en) * 2008-07-29 2013-08-07 皇家飞利浦电子股份有限公司 System and method for communicating information between implantable devices
AU2009281876B2 (en) 2008-08-13 2014-05-22 Proteus Digital Health, Inc. Ingestible circuitry
KR101192690B1 (en) 2008-11-13 2012-10-19 프로테우스 디지털 헬스, 인코포레이티드 Ingestible therapy activator system, therapeutic device and method
US8055334B2 (en) 2008-12-11 2011-11-08 Proteus Biomedical, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
TWI424832B (en) 2008-12-15 2014-02-01 Proteus Digital Health Inc Body-associated receiver and method
WO2013012869A1 (en) 2011-07-21 2013-01-24 Proteus Digital Health, Inc. Mobile communication device, system, and method
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
JP2012514799A (en) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド Methods and systems for ingestion related biofeedback and individual pharmacotherapy
EP3395333A1 (en) 2009-01-06 2018-10-31 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US9161693B2 (en) * 2009-03-19 2015-10-20 University Of Florida Research Foundation, Inc. Miniaturized electronic device ingestible by a subject or implantable inside a body of the subject
WO2010111403A2 (en) 2009-03-25 2010-09-30 Proteus Biomedical, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
CN102458236B (en) 2009-04-28 2016-01-27 普罗秋斯数字健康公司 The Ingestible event marker of high reliability and using method thereof
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US8656916B2 (en) * 2009-06-24 2014-02-25 Igor Stukanov Intravaginal device with wireless sensors on a contraceptive barrier
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US9192353B2 (en) * 2009-10-27 2015-11-24 Innurvation, Inc. Data transmission via wide band acoustic channels
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
UA109424C2 (en) 2009-12-02 2015-08-25 PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS
SG182825A1 (en) 2010-02-01 2012-09-27 Proteus Biomedical Inc Data gathering system
US8647259B2 (en) 2010-03-26 2014-02-11 Innurvation, Inc. Ultrasound scanning capsule endoscope (USCE)
BR112012025650A2 (en) 2010-04-07 2020-08-18 Proteus Digital Health, Inc. miniature ingestible device
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
US9044616B2 (en) * 2010-07-01 2015-06-02 Boston Scientific Neuromodulation Corporation Charging system for an implantable medical device employing magnetic and electric fields
US9867990B2 (en) * 2010-10-29 2018-01-16 Medtronic, Inc. Determination of dipole for tissue conductance communication
JP2014504902A (en) 2010-11-22 2014-02-27 プロテウス デジタル ヘルス, インコーポレイテッド Ingestible device with medicinal product
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
CA2834786A1 (en) 2011-05-06 2012-11-15 Ndsu Research Foundation Intelligent self-organizing electrode stimulation delivery system
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
SG11201503027SA (en) 2012-10-18 2015-05-28 Proteus Digital Health Inc Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
AU2013342014B2 (en) 2012-11-12 2017-04-13 Empi, Inc. Systems and methods for wireless pairing and communication for electrostimulation
JP2016508529A (en) 2013-01-29 2016-03-22 プロテウス デジタル ヘルス, インコーポレイテッド Highly expandable polymer film and composition containing the same
EP2953524B1 (en) 2013-02-06 2018-08-01 Freenome Holdings Inc. Systems and methods for early disease detection and real-time disease monitoring
WO2014151929A1 (en) 2013-03-15 2014-09-25 Proteus Digital Health, Inc. Personal authentication apparatus system and method
JP5941240B2 (en) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス, インコーポレイテッド Metal detector device, system and method
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
EP3047618B1 (en) 2013-09-20 2023-11-08 Otsuka Pharmaceutical Co., Ltd. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
JP2016537924A (en) 2013-09-24 2016-12-01 プロテウス デジタル ヘルス, インコーポレイテッド Method and apparatus for use with electromagnetic signals received at frequencies that are not accurately known in advance
US9700234B2 (en) 2013-09-30 2017-07-11 University of Pittsburgh—of the Commonwealth System of Higher Education System and method for storing information relating to a medical implant device
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
EP3092034B1 (en) 2014-01-10 2019-10-30 Cardiac Pacemakers, Inc. Systems for detecting cardiac arrhythmias
WO2015106007A1 (en) 2014-01-10 2015-07-16 Cardiac Pacemakers, Inc. Methods and systems for improved communication between medical devices
US9694189B2 (en) 2014-08-06 2017-07-04 Cardiac Pacemakers, Inc. Method and apparatus for communicating between medical devices
US9757570B2 (en) 2014-08-06 2017-09-12 Cardiac Pacemakers, Inc. Communications in a medical device system
US9808631B2 (en) 2014-08-06 2017-11-07 Cardiac Pacemakers, Inc. Communication between a plurality of medical devices using time delays between communication pulses to distinguish between symbols
EP3185952B1 (en) 2014-08-28 2018-07-25 Cardiac Pacemakers, Inc. Implantable cardiac rhythm system and an associated method for triggering a blanking period through a second device
AU2016215606B2 (en) 2015-02-06 2018-05-31 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
US10220213B2 (en) 2015-02-06 2019-03-05 Cardiac Pacemakers, Inc. Systems and methods for safe delivery of electrical stimulation therapy
US10046167B2 (en) 2015-02-09 2018-08-14 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
WO2016141046A1 (en) 2015-03-04 2016-09-09 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
JP6515195B2 (en) 2015-03-18 2019-05-15 カーディアック ペースメイカーズ, インコーポレイテッド Implantable medical device and medical system
CN104967212A (en) * 2015-07-17 2015-10-07 河南行知专利服务有限公司 Complementary power supply method for implanted device
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
WO2017031221A1 (en) 2015-08-20 2017-02-23 Cardiac Pacemakers, Inc. Systems and methods for communication between medical devices
CN108136187B (en) 2015-08-20 2021-06-29 心脏起搏器股份公司 System and method for communication between medical devices
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
WO2017040115A1 (en) 2015-08-28 2017-03-09 Cardiac Pacemakers, Inc. System for detecting tamponade
US10137305B2 (en) 2015-08-28 2018-11-27 Cardiac Pacemakers, Inc. Systems and methods for behaviorally responsive signal detection and therapy delivery
US10092760B2 (en) 2015-09-11 2018-10-09 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
EP3359251B1 (en) 2015-10-08 2019-08-07 Cardiac Pacemakers, Inc. Adjusting pacing rates in an implantable medical device
CA3002841C (en) 2015-10-21 2024-03-19 NeuSpera Medical Inc. Devices, systems, and methods for stimulation therapy
US10183170B2 (en) 2015-12-17 2019-01-22 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
US10905886B2 (en) 2015-12-28 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device for deployment across the atrioventricular septum
US10583303B2 (en) 2016-01-19 2020-03-10 Cardiac Pacemakers, Inc. Devices and methods for wirelessly recharging a rechargeable battery of an implantable medical device
CN109069840B (en) 2016-02-04 2022-03-15 心脏起搏器股份公司 Delivery system with force sensor for leadless cardiac devices
CN108883286B (en) 2016-03-31 2021-12-07 心脏起搏器股份公司 Implantable medical device with rechargeable battery
US10668294B2 (en) 2016-05-10 2020-06-02 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker configured for over the wire delivery
US10328272B2 (en) 2016-05-10 2019-06-25 Cardiac Pacemakers, Inc. Retrievability for implantable medical devices
WO2018005373A1 (en) 2016-06-27 2018-01-04 Cardiac Pacemakers, Inc. Cardiac therapy system using subcutaneously sensed p-waves for resynchronization pacing management
US11207527B2 (en) 2016-07-06 2021-12-28 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
WO2018009392A1 (en) 2016-07-07 2018-01-11 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
WO2018017226A1 (en) 2016-07-20 2018-01-25 Cardiac Pacemakers, Inc. System for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
KR102051875B1 (en) 2016-07-22 2019-12-04 프로테우스 디지털 헬스, 인코포레이티드 Electromagnetic detection and detection of ingestible event markers
WO2018035343A1 (en) 2016-08-19 2018-02-22 Cardiac Pacemakers, Inc. Trans septal implantable medical device
EP3503970B1 (en) 2016-08-24 2023-01-04 Cardiac Pacemakers, Inc. Cardiac resynchronization using fusion promotion for timing management
US10780278B2 (en) 2016-08-24 2020-09-22 Cardiac Pacemakers, Inc. Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing
US10758737B2 (en) 2016-09-21 2020-09-01 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
WO2018057318A1 (en) 2016-09-21 2018-03-29 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
WO2018057626A1 (en) 2016-09-21 2018-03-29 Cardiac Pacemakers, Inc. Implantable cardiac monitor
EP3531901A4 (en) 2016-10-26 2021-01-27 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers
WO2018081275A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
EP3532160B1 (en) 2016-10-27 2023-01-25 Cardiac Pacemakers, Inc. Separate device in managing the pace pulse energy of a cardiac pacemaker
EP3532159B1 (en) 2016-10-27 2021-12-22 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
JP7038115B2 (en) 2016-10-27 2022-03-17 カーディアック ペースメイカーズ, インコーポレイテッド Implantable medical device with pressure sensor
US10561330B2 (en) 2016-10-27 2020-02-18 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
US10413733B2 (en) 2016-10-27 2019-09-17 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
CN109952128B (en) 2016-10-31 2023-06-13 心脏起搏器股份公司 System for activity level pacing
WO2018081713A1 (en) 2016-10-31 2018-05-03 Cardiac Pacemakers, Inc Systems for activity level pacing
WO2018089311A1 (en) 2016-11-08 2018-05-17 Cardiac Pacemakers, Inc Implantable medical device for atrial deployment
EP3538213B1 (en) 2016-11-09 2023-04-12 Cardiac Pacemakers, Inc. Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device
EP3541471B1 (en) 2016-11-21 2021-01-20 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker providing cardiac resynchronization therapy
EP3541473B1 (en) 2016-11-21 2020-11-11 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with multimode communication
US10639486B2 (en) 2016-11-21 2020-05-05 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
US10881869B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
WO2018094342A1 (en) 2016-11-21 2018-05-24 Cardiac Pacemakers, Inc Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing
US11207532B2 (en) 2017-01-04 2021-12-28 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
AU2018213326B2 (en) 2017-01-26 2020-09-10 Cardiac Pacemakers, Inc. Intra-body device communication with redundant message transmission
WO2018140623A1 (en) 2017-01-26 2018-08-02 Cardiac Pacemakers, Inc. Leadless device with overmolded components
CN110198759B (en) 2017-01-26 2023-08-11 心脏起搏器股份公司 Leadless implantable device with removable fasteners
US10905872B2 (en) 2017-04-03 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
CN110740779B (en) 2017-04-03 2024-03-08 心脏起搏器股份公司 Cardiac pacemaker with pacing pulse energy modulation based on sensed heart rate
EP3630230A4 (en) 2017-05-21 2020-12-30 Oncodisc, Inc. Low profile implantable medication infusion port with electronic localization, physiologic monitoring, and data transfer
EP3668592B1 (en) 2017-08-18 2021-11-17 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
US10918875B2 (en) 2017-08-18 2021-02-16 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
JP2020532031A (en) 2017-08-23 2020-11-05 ニューラブル インコーポレイテッド Brain-computer interface with high-speed optotype tracking
WO2019060302A1 (en) 2017-09-20 2019-03-28 Cardiac Pacemakers, Inc. Implantable medical device with multiple modes of operation
US11185703B2 (en) 2017-11-07 2021-11-30 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
US11813463B2 (en) 2017-12-01 2023-11-14 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with reversionary behavior
US11071870B2 (en) 2017-12-01 2021-07-27 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
US11052258B2 (en) 2017-12-01 2021-07-06 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker
US11260216B2 (en) 2017-12-01 2022-03-01 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials during ventricular filling from a ventricularly implanted leadless cardiac pacemaker
US11529523B2 (en) 2018-01-04 2022-12-20 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
CN111556773A (en) 2018-01-04 2020-08-18 心脏起搏器股份公司 Dual chamber pacing without beat-to-beat communication
US11400296B2 (en) 2018-03-23 2022-08-02 Medtronic, Inc. AV synchronous VfA cardiac therapy
JP2021518192A (en) 2018-03-23 2021-08-02 メドトロニック,インコーポレイテッド VfA cardiac resynchronization therapy
JP2021519117A (en) 2018-03-23 2021-08-10 メドトロニック,インコーポレイテッド VfA Cardiac Treatment for Tachycardia
US10664050B2 (en) 2018-09-21 2020-05-26 Neurable Inc. Human-computer interface using high-speed and accurate tracking of user interactions
CN112770807A (en) 2018-09-26 2021-05-07 美敦力公司 Capture in atrial-to-ventricular cardiac therapy
US11951313B2 (en) 2018-11-17 2024-04-09 Medtronic, Inc. VFA delivery systems and methods
US11096582B2 (en) 2018-11-20 2021-08-24 Veris Health Inc. Vascular access devices, systems, and methods for monitoring patient health
US11679265B2 (en) 2019-02-14 2023-06-20 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
US11697025B2 (en) 2019-03-29 2023-07-11 Medtronic, Inc. Cardiac conduction system capture
US11213676B2 (en) 2019-04-01 2022-01-04 Medtronic, Inc. Delivery systems for VfA cardiac therapy
US11712188B2 (en) 2019-05-07 2023-08-01 Medtronic, Inc. Posterior left bundle branch engagement
US20200367749A1 (en) * 2019-05-20 2020-11-26 Brown University Implantable wireless network of distributed microscale sensors
US11065461B2 (en) 2019-07-08 2021-07-20 Bioness Inc. Implantable power adapter
US11305127B2 (en) 2019-08-26 2022-04-19 Medtronic Inc. VfA delivery and implant region detection
US11813466B2 (en) 2020-01-27 2023-11-14 Medtronic, Inc. Atrioventricular nodal stimulation
US11911168B2 (en) 2020-04-03 2024-02-27 Medtronic, Inc. Cardiac conduction system therapy benefit determination
US11813464B2 (en) 2020-07-31 2023-11-14 Medtronic, Inc. Cardiac conduction system evaluation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6076016A (en) * 1995-10-19 2000-06-13 Feierbach; Gary F. Galvanic transdermal conduction communication system and method
US6167310A (en) * 1999-03-31 2000-12-26 Medtronic, Inc. Downlink telemetry system and method for implantable medical device
US6289237B1 (en) * 1998-12-22 2001-09-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Apparatus for energizing a remote station and related method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740813A1 (en) * 1977-09-10 1979-03-22 Leonhardt Fritz REFLECTOR
DE19646622B4 (en) * 1996-11-12 2004-07-01 Wacker Construction Equipment Ag Tool that can be carried in one movement
US6754472B1 (en) 2000-04-27 2004-06-22 Microsoft Corporation Method and apparatus for transmitting power and data using the human body
US6845253B1 (en) * 2000-09-27 2005-01-18 Time Domain Corporation Electromagnetic antenna apparatus
EA007443B1 (en) * 2001-08-03 2006-10-27 Бейкер Хьюз Инкорпорейтед A method and apparatus for a multi-component induction instrument measuring system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6076016A (en) * 1995-10-19 2000-06-13 Feierbach; Gary F. Galvanic transdermal conduction communication system and method
US6289237B1 (en) * 1998-12-22 2001-09-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Apparatus for energizing a remote station and related method
US6167310A (en) * 1999-03-31 2000-12-26 Medtronic, Inc. Downlink telemetry system and method for implantable medical device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9365649B2 (en) 2003-04-14 2016-06-14 Xintela Ab Monoclonal antibody capable of binding integrin alpha 10 beta 1

Also Published As

Publication number Publication date
US7228183B2 (en) 2007-06-05
WO2003105492A3 (en) 2004-03-25
US20040199222A1 (en) 2004-10-07
AU2003237263A1 (en) 2003-12-22
AU2003237263A8 (en) 2003-12-22
US20030229382A1 (en) 2003-12-11
US6847844B2 (en) 2005-01-25

Similar Documents

Publication Publication Date Title
US6847844B2 (en) Method of data communication with implanted device and associated apparatus
US8494637B2 (en) Systems and methods for implantable leadless gastrointestinal tissue stimulation
US7672734B2 (en) Non-linear electrode array
US9248301B2 (en) System and method for communicating information between implantable devices
Bashirullah Wireless implants
US8615294B2 (en) Electrode devices for nerve stimulation and cardiac sensing
US8359107B2 (en) Electrode design for leads of implantable electric stimulation systems and methods of making and using
US6453199B1 (en) Electrical gastro-intestinal tract stimulator
EP2575955B1 (en) Electrode assembly with magnetic connection
US20120108993A1 (en) Electrode shapes and positions for reducing loss of contact in an implantable ecg recorder
JPH07265441A (en) Electrode device
AU2007235178A1 (en) Non-linear electrode array
CN104716751A (en) Wearable wireless energy transmission device and method
EP1427475A2 (en) Electrostimulating device
Sun et al. How to pass information and deliver energy to a network of implantable devices within the human body
CN109745031A (en) Collect the medical device of electrocardio and physiology sound
CN210897611U (en) Capsule antenna with reconfigurable directional diagram
CN213667526U (en) Wearable ultrasonic iontophoresis transdermal drug delivery system
EP4212205B1 (en) System for powering and controlling the electronics of minimally invasive stimulation or monitoring devices implantable in head or neck body regions
US20240050756A1 (en) Intra-Body Network System
JP2006166958A (en) In vivo medical device
CN114470523A (en) Moulding magnetic stimulation appearance
CN116350946A (en) Heart rate management system with double-cavity working mode
Sahrani et al. Electromagnetic interference on artificial heart pacemaker
CN110384861A (en) Injection type PZT (piezoelectric transducer), injection device, neural stimulation system and method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP